Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective.
about
Interferon for people with lamivudine-resistant chronic hepatitis B virus infectionAdefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infectionChange of strategies and future perspectives against hepatitis B virus recurrence after liver transplantationApplication of nucleoside analogues to liver transplant recipients with hepatitis BHepatitis B virus and its sexually transmitted infection - an update.Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsClinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin.Liver transplantation in adults: Choosing the appropriate timingSuccessful reuse of liver grafts after death of the first recipient.Strategies for the prevention of infection after solid organ transplantation.Prophylaxis of hepatitis B infection in solid organ transplant recipients.Treatment of chronic hepatitis B infection: an update of Swedish recommendations.Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.Hepatitis B immunoglobulin in preventing reinfection following liver transplantation.Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.Treatment of special populations with chronic hepatitis B infection.Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation.Hepatitis B immune globulin in liver transplantation prophylaxis: an update.Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.Hepatitis B recurrence after liver transplantation: a single center experiences and review the literature.Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17-year experience at a single center.Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on.Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy.A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis.Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver-transplanted for Hepatitis B Virus-related Cirrhosis at Low Risk of Hepatitis B Virus Recurrence.Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection.Outcome of various treatments for posttransplant hepatitis B virus recurrence.Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study.Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
P2860
Q24185973-38CC9CED-329E-4608-9458-BD1711A81A1FQ24187530-E51EFCC3-6856-4171-BDC6-D94C28B00575Q26784241-FF0FF99E-A218-44F9-A028-6082E73CDA6AQ26859796-346C40B0-1F01-4C2F-B06C-674A1AC2073EQ30235028-951F74FF-5461-43B2-86B5-6AAE105232C2Q33624284-D36871B4-7BD6-444B-AF82-13E7EFE53BB3Q33891744-1304C248-0C2E-4117-9C1D-E2D023CC0DF4Q34029115-1A77C1F3-C3BA-4963-B5E0-E3DA1C99550DQ34175570-D12F126A-BBCE-4694-94DD-DAE012739091Q35582445-608E3118-C471-4272-826F-044B9942DD9BQ36220176-090C357F-E9F2-4577-9970-327FAF71F2B3Q36591745-2FD0B4F1-5A10-477B-8457-B39EF96D1F4EQ36670902-F88BBA2B-BF91-42D2-8375-86CA7B4F4845Q36886518-FD571632-15A4-4B39-BE7B-147A1E352D4EQ37201573-80CA24C2-D2DA-4262-8609-D33030700EAEQ37217853-46CEBB00-86B8-4800-BCC4-4A7500C6BAB1Q37432104-43355B7F-F069-4305-B4FE-D7259DD9EDD0Q37764964-5188D4B7-17C3-4A14-93B8-06DEF54CFBADQ37886158-5A5BEEAA-76A9-4364-92A2-C7904A51DE7DQ37905782-015EA3D8-3D32-4100-87FB-EFF5540F123BQ38006958-F00C4E56-6B91-482C-A9ED-8DAB833329A3Q38061056-D6E4F957-EEB5-4CAA-AC86-6FE4D2BE4C4DQ38088688-1F47CC00-2F83-407E-ACCD-37074CD3057CQ38320548-460E9C0F-7347-4B0C-ACD2-11F55CA590FEQ38475751-750EBF12-305B-419F-AEF2-7804306B8CD6Q40302269-F0AD2BF4-F47A-465F-AFD9-725599017BE1Q40333032-52155B1D-938D-4E36-AE1C-3181D3F92E40Q41037062-1B15D288-EB1B-46B7-BC74-69DF7DC32F59Q41992383-FBC02E92-7F64-492D-922F-392A9D427F8AQ42144316-BE25AF96-6A29-4E11-B98D-10050B279C17Q42222635-D3BD0BA3-EE59-4FDE-9A16-177976DF6E50Q42244681-83A143F4-F05D-4B1A-8E8C-D74379933449Q42439836-86805464-CA0E-4440-8876-4B6C554FAFFCQ43606309-7300405E-8DA2-4669-AD61-148F60342930Q43714307-DEED5C26-0B93-4B47-9AFF-EBF631567C7EQ43756998-1DC27503-117D-4CB3-882D-1DA66F4E72DFQ45388069-E0908BB6-38E1-4494-AF10-3E7A2DBAC572Q50889818-31891241-3C6B-461A-8FF0-6DB90EA1CE20
P2860
Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Management of the hepatitis B ...... n and an American perspective.
@ast
Management of the hepatitis B ...... n and an American perspective.
@en
Management of the hepatitis B ...... n and an American perspective.
@nl
type
label
Management of the hepatitis B ...... n and an American perspective.
@ast
Management of the hepatitis B ...... n and an American perspective.
@en
Management of the hepatitis B ...... n and an American perspective.
@nl
prefLabel
Management of the hepatitis B ...... n and an American perspective.
@ast
Management of the hepatitis B ...... n and an American perspective.
@en
Management of the hepatitis B ...... n and an American perspective.
@nl
P2093
P356
P1476
Management of the hepatitis B ...... n and an American perspective.
@en
P2093
Bruno Roche
Didier Samuel
Norah Terrault
P304
P356
10.1002/LT.20492
P577
2005-07-01T00:00:00Z